[국제]EU, Pfizer vaccination from tomorrow…’mutant virus’ variable

[앵커]

European Union countries will begin vaccinating COVID-19 from tomorrow (27th).

Amid fears of the spread of the mutant virus from the UK, European countries are starting the new year with hope for a vaccine.

Reporter Jo Soo-hyun reports.

[기자]

As announced by the European Union’s EU executive, the approval of the emergency use of the Pfizer vaccine has become a’Christmas gift’ for EU citizens.

Between 27 and 29 local time, the 27 member states begin vaccination as soon as they are ready.

Germany, France, Italy, Spain and Austria have a policy to start vaccination on the 27th.

Vaccines must be delivered to hospitals and public health centers across the country in cryogenic conditions, and some countries are expected to take another day or two depending on conditions.

The EU did not disclose the primary supply volume.

However, it continues to emphasize that all member states are distributed on fair terms.

[우르줄라 폰데어라이엔 / EU 집행위원장 : 약속한 대로 백신은 모든 EU 회원국에 동시에, 동일한 조건으로 제공될 것입니다.]

Amidst this, the possibility of spreading the second COVID-19 mutant virus identified in the UK has emerged as a variable of vaccine efficacy.

[맷 행콕 / 영국 보건부 장관 : 새로운 변이는 전염력이 더 강하고 첫 번째 변이보다도 더 많이 변형된 것으로 보여 매우 우려스럽습니다.]

Pfizer and Bioentech, who co-developed the vaccine, are conducting experiments to confirm the efficacy of the vaccine against mutant viruses, and we are interested in how the results will come out.

Along with this, although EU countries started vaccination in a united form, it remains a task to be able to ensure that countries can receive an equal supply of vaccines until the end of all national vaccinations in the future.

This is YTN Soohyun Cho.

[저작권자(c) YTN & YTN plus 무단전재 및 재배포 금지]

– .